ACVRL1 is the pathogenic gene of type 2 hereditary hemorrhagic telangiectasia (HHT2), and there’s no NVM reported to be associated with ACVRL1 mutation. This evidence concerns the gene ACVRL1 and hereditary hemorrhagic telangiectasia.